Commensalism or symbiosis: The potential use of rituximab in steroid-refractory Evans syndrome in a patient with ulcerative colitis.
作者信息
Ahmed Eyad, Hoe Chan Kok, Veeraballi Sindhusha, Dacosta Theodore, Shaaban Hamid
机构信息
Department of Internal Medicine, Saint Michael's Medical Center, New York Medical College, Newark, United States.
Department of Gastroenterology, Saint Michael's Medical Center, New York Medical College, Newark, United States.
出版信息
Arch Rheumatol. 2021 Oct 18;37(1):156-157. doi: 10.46497/ArchRheumatol.2022.8898. eCollection 2022 Mar.
Abstract
摘要
相似文献
1
Commensalism or symbiosis: The potential use of rituximab in steroid-refractory Evans syndrome in a patient with ulcerative colitis.
Arch Rheumatol. 2021 Oct 18;37(1):156-157. doi: 10.46497/ArchRheumatol.2022.8898. eCollection 2022 Mar.
2
The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection: a prospective multicenter study.
J Clin Gastroenterol. 2012 Jan;46(1):51-6. doi: 10.1097/MCG.0b013e3182160c9c.
3
Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.
World J Gastroenterol. 2019 Apr 7;25(13):1603-1617. doi: 10.3748/wjg.v25.i13.1603.
4
Phosphatidylcholine for steroid-refractory chronic ulcerative colitis: a randomized trial.
Ann Intern Med. 2007 Nov 6;147(9):603-10. doi: 10.7326/0003-4819-147-9-200711060-00004.
5
Prevalence, detection rate and outcome of cytomegalovirus infection in ulcerative colitis patients requiring colonic resection.
Dig Liver Dis. 2005 Jun;37(6):418-23. doi: 10.1016/j.dld.2005.01.011. Epub 2005 Mar 16.
6
Oral microemulsion cyclosporine in the treatment of steroid-refractory attacks of ulcerative and indeterminate colitis.
Scand J Gastroenterol. 2001 Jun;36(6):610-4. doi: 10.1080/003655201750163051.
7
Tacrolimus Therapy in Steroid-Refractory Ulcerative Colitis: A Review.
Inflamm Bowel Dis. 2020 Jan 1;26(1):24-32. doi: 10.1093/ibd/izz068.
8
[Infliximab in moderate to severe steroid-dependent or steroid-refractory ulcerative colitis].
Recenti Prog Med. 2007 Nov;98(11):560-4.
9
A patient with mixed type Evans syndrome: efficacy of rituximab treatment.
J Korean Med Sci. 2006 Dec;21(6):1115-6. doi: 10.3346/jkms.2006.21.6.1115.
10
Low molecular weight heparin treatment in steroid refractory ulcerative colitis: clinical outcome and influence on mucosal capillary thrombi.
Scand J Gastroenterol Suppl. 2001(234):41-7. doi: 10.1080/003655201753265091.
本文引用的文献
1
Evans syndrome: clinical perspectives, biological insights and treatment modalities.
J Blood Med. 2018 Oct 10;9:171-184. doi: 10.2147/JBM.S176144. eCollection 2018.
2
Fulminant Colitis Following Rituximab Therapy.
Gastroenterol Hepatol (N Y). 2016 Jan;12(1):58-60.
3
Randomised placebo-controlled trial of rituximab (anti-CD20) in active ulcerative colitis.
Gut. 2011 Nov;60(11):1520-6. doi: 10.1136/gut.2010.225482. Epub 2011 Apr 6.
4
Severe ulcerative colitis after rituximab therapy.
Pediatrics. 2010 Jul;126(1):e243-6. doi: 10.1542/peds.2009-3395. Epub 2010 Jun 21.
5
Successful use of rituximab in Evans syndrome and refractory immune thrombocytopenic purpura.
J Pak Med Assoc. 2010 Jan;60(1):64-5.
6
Management of Evans syndrome.
Br J Haematol. 2006 Jan;132(2):125-37. doi: 10.1111/j.1365-2141.2005.05809.x.
7
Serologic markers in inflammatory bowel disease.
Clin Chem. 2006 Feb;52(2):171-81. doi: 10.1373/clinchem.2005.058560. Epub 2005 Dec 8.
Zotero 插件